Regenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, is playing a crucial role in the creation of a groundbreaking publication on artificial intelligence in healthcare from the National Academy of Medicine. The document is viewed as a reference for all stakeholders involved in AI and healthcare. Dr. Mendonca is a co-lead on the chapter considering the tradeoffs and unintended consequences of AI and a co-author on the chapter exploring the deployment of AI in clinical settings. She stresses the importance of carefully monitoring the uses and outcomes after AI implementation to correct any negative consequences and the adoption of general IT governance structures to manage AI. The publication is called “Artificial Intelligence in Health Care: The Hope, The Hype, The Promise, and The Peril.”
-
Research
- Experts
In The News
View AllMedical Xpress features Dr. Alexia Torke
Alexia M. Torke, M.D., M.S., was featured by Medical Xpress...
Influence
View AllPredicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling
Published in the Alzheimer’s & Dementia: The Journal of the...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts
Influence
January 9, 2020
Regenstrief VP breaking ground in artificial intelligence education in conjunction with National Academy of Medicine, other partners
Related News
News
March 7, 2025
LOINC® biannual stakeholder webinar to highlight latest updates and strategic initiatives
LOINC® from Regenstrief Institute will host a biannual stakeholder meeting on March 25, 2025. During the meeting, held via
News
March 5, 2025
AI model predicting two-year risk of common heart disorder can easily be integrated into healthcare workflow
Non-invasive, inexpensive approach provides a practical option for proactive screening INDIANAPOLIS – AFib (short for atrial fibrillation), a common
Influence
February 28, 2025
Predicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling
Published in the Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. Here is a link to the article.
"*" indicates required fields